![]() Midatech Pharma Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines. | ![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ![]() KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date 2006 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cardiff, GB HQ Milton, GB | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US |
Employees | Employees 8414% increase | Employees 39 | Employees 333% increase |
Valuation ($) | Valuation ($) 38.7 m | Valuation ($) N/A | Valuation ($) 200.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) $106.5m (FY, 2025) |
Net income | Net income (£6.4m) (FY, 2025) | Net income (£2.6m) (FY, 2018) | Net income $83.2m (FY, 2025) |

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View company